Lexeo Therapeutics LXEO
NASDAQ LXEO
$2.89 -0.11 (-3.67%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Other financing activities (2023 - 2025)

Updated

Lexeo Therapeutics (LXEO) reported Other financing activities of $75,000 for Q4 2023.

Analysis

Lexeo Therapeutics (LXEO) Other financing activities (2023 - 2025) Analysis & Trends

For FY2023, Lexeo Therapeutics posted Other financing activities of $86,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Lexeo Therapeutics 248.75 Mn -411.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17,000.00
Jun 30, 2025 -6,917.00
Dec 31, 2023 -75,000.00
API Access

Lexeo Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LXEO&period=max&api_key=YOUR_API_KEY